• Title/Summary/Keyword: positron

Search Result 697, Processing Time 0.029 seconds

Positron emission tomography and magnetic resonance imaging

  • Yim, Min Su;Ryu, Eun Kyoung
    • Journal of Radiopharmaceuticals and Molecular Probes
    • /
    • v.2 no.1
    • /
    • pp.3-8
    • /
    • 2016
  • Molecular imaging technologies have been used to provide a new pathway for therapies and diagnosis of human disease. Especially, imaging probes have been much development in the molecular imaging field. Combining imaging probes for positron emission tomography (PET) and magnetic resonance imaging (MRI) have suggested the potential of multiple methods in living body. This review discusses the cancer or lymph node-targeting probes that are suitable for PET/MRI based diagnosis.

A novel tricyclic derivative for PET imaging of the translocator protein

  • Kwon, Young-Do;Kim, Hee-Kwon
    • Journal of Radiopharmaceuticals and Molecular Probes
    • /
    • v.2 no.1
    • /
    • pp.37-42
    • /
    • 2016
  • The translocator protein (TSPO) has attracted scientist's attention for Positron Emission Tomography (PET) imaging due to correlation with brain cancer, stroke, and neurodegeneration. Recently, GE-180, a novel tricyclic derivative has been developed as a new high affinity agent for the TSPO and evaluated to confirm a possibility for the TSPO ligand. In this highlight review, several studies for the novel TSPO radiotracer are described.

Radiopharmaceuticals for Imaging of Cellular Proliferation (세포 증식 영상용 방사성의약품)

  • Oh, Seung-Jun
    • The Korean Journal of Nuclear Medicine
    • /
    • v.36 no.4
    • /
    • pp.209-223
    • /
    • 2002
  • By considering the biological properties of a tumor, it should be possible to realize better results in cancer therapy. PET imaging offers the opportunity to measure tumor growth non-invasively and repeatedly as an early assessment of response to cancer therapy. Measuring cellular growth instead of energy metabolism showed offer significant advantages in evaluating therapy. Thymidine and its derivative nucleoside compounds can be changed to mono, di- and tri- phosphate compounds by thymidine kinase and then be incorporated into DNA. Their bindings are increased in highly proliferating cells due to the high DNA synthesis rate. To evaluate cell proliferation, many kinds of thymidine and uridine derivatives have been labeled with positron emitter and radioactive iodine. Compared to radiopharmaceuticals which have radioisotope labeled base ring such as pyirmidine, the radiopharmacuticals which have radioisotope labeled sugar ring are more stable in vivo and have metabolic resistance. The biological properties such as DNA incorporation ratios are highly dependent on their chemical structures and metabolic processes. This overview describes synthesis of radiopharmaceuticals and their biological properties for imaging of tumor cell proliferation.

Primary Intracranial Malignant Melanoma with Extracranial Metastasis

  • Hirota, Kengo;Yoshimura, Chika;Kubo, Osami;Kasuya, Hidetoshi
    • Journal of Korean Neurosurgical Society
    • /
    • v.60 no.1
    • /
    • pp.98-101
    • /
    • 2017
  • We report a case of primary intracranial malignant melanoma (PIMM) with extracranial metastases. The patient was an 82-year-old woman diagnosed with PIMM under the left cerebellar tentorium. We performed a tumor resection followed by gamma knife surgery. An magnetic resonance imaging at 11 months after surgery showed a local intracranial recurrence. At 12 months, vertebral metastasis was suspected, and 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (FDG-PET/CT) showed multiple extracranial metastases. She died at 13 months after surgery. Although extracranial metastases of PIMM are extremely rare, we should carefully follow up extracranial metastases together with intracranial ones, especially by FDG-PET/CT, even at an early asymptomatic stage.

Beta-amyloid imaging in dementia

  • Chun, Kyung Ah
    • Journal of Yeungnam Medical Science
    • /
    • v.35 no.1
    • /
    • pp.1-6
    • /
    • 2018
  • Alzheimer's disease (AD) is a neurodegenerative disorder associated with extracellular plaques, composed of amyloid-beta ($A{\beta}$), in the brain. Although the precise mechanism underlying the neurotoxicity of $A{\beta}$ has not been established, $A{\beta}$ accumulation is the primary event in a cascade of events that lead to neurofibrillary degeneration and dementia. In particular, the $A{\beta}$ burden, as assessed by neuroimaging, has proved to be an excellent predictive biomarker. Positron emission tomography, using ligands such as $^{11}C$-labeled Pittsburgh Compound B or $^{18}F$-labeled tracers, such as $^{18}F$-florbetaben, $^{18}F$-florbetapir, and $^{18}F$-flutemetamol, which bind to $A{\beta}$ deposits in the brain, has been a valuable technique for visualizing and quantifying the deposition of $A{\beta}$ throughout the brain in living subjects. $A{\beta}$ imaging has very high sensitivity for detecting AD pathology. In addition, it can predict the progression from mild cognitive impairment to AD, and contribute to the development of disease-specific therapies.

Study of Dark Matter at e+e- Collider using KISTI-5 Supercomputer

  • Park, Kihong;Cho, Kihyeon
    • International Journal of Contents
    • /
    • v.17 no.3
    • /
    • pp.67-73
    • /
    • 2021
  • Dark matter is barely known because it cannot be explained using the Standard Model. In addition, dark matter has not been detected yet. It is currently being explored through various ways. In this paper, we studied dark matter in an electron-positron collider using MadGraph5. The signal channel is e+e- → 𝜇+𝜇-A' where A' decays to dimuon. We studied the cross-section by increasing the center-of-mass energy. Central processing unit (CPU) time of simulation was compared with that using a local Linux machine and a KISTI-5 supercomputer (Knight Landing and Skylake). Furthermore, one or more cores were used for comparing CPU time among machines. Results of this study will enable the exploration of dark matter in electron-positron experiments. This study also serves as a reference for optimizing high-energy physics simulation toolkits.

Radiolabeled 2D graphitic nanomaterials and their possibility for molecular imaging applications

  • Kang, Seok Min;Kim, Chul Hee;Kim, Dong Wook
    • Journal of Radiopharmaceuticals and Molecular Probes
    • /
    • v.4 no.2
    • /
    • pp.115-120
    • /
    • 2018
  • In recent years, many researchers have attempted to make use of 2D nanoparticles as molecular imaging probes since extensive investigations proved that 2D nanoparticles in the body tends to accumulate certain lesions by enhanced permeability and retention (EPR) effect. For example, graphene and carbon nitride which have high surface area and modifiable properties showed good biocompatibility and targetability when it used as imaging probes. However, poor dispersibility in physiological mediums and its uncontrolled size limited its usage in bio-application. Therefore, oxidation process and mechanical exfoliation have been developed for overcoming these problems. In this paper, we highlight the several major methods to synthesize biocompatible 2D nanomaterials like graphene and carbon nitride especially for molecular imaging study including positron emission tomography (PET).

Development of radiolabelled histone deacetylase inhibitors for PET imaging study

  • Hee-Kwon Kim
    • Journal of Radiopharmaceuticals and Molecular Probes
    • /
    • v.6 no.2
    • /
    • pp.165-170
    • /
    • 2020
  • Histone Deacetylases (HDACs) are enzymes that have control gene expression regulation and cell state. In additions, inhibitions of HDACs are associated with growth arrest, differentiation, or apoptosis of tumor cell. Thus HDAC inhibition is one of the interesting biological targets. A variety of HDAC inhibitors has been developed by many scientists, and some of chemical structures related with HDAC inhibitors were modified to give radiolabeled HDAC inhibitors for positron emission tomography (PET) study. In this highlight review, the development of radiolabeled HDAC inhibitors for PET study are described.